TickerFacts.

Bionano Genomics, Inc. (BNGO): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

Older than the company's other figures. The latest Free Cash Flow is for the year ended 2020-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report Capital Expenditures, which Free Cash Flow is computed from, under the concepts TickerFacts maps.

-$38.31M
Year ended 2020-12-31
2017-12-31: -$21.84M2018-12-31: -$20.28M2019-12-31: -$29.59M2020-12-31: -$38.31M-$38.31M
2017-12-31 Free Cash Flow (USD) 2020-12-31
Period endedFree Cash FlowChange YoYSource filing
2020-12-31-$38.31Mn/m2022-03-01, From 2020-01-01
2019-12-31-$29.59Mn/m2021-03-23, From 2019-01-01
2018-12-31-$20.28Mn/m2020-03-10, From 2018-01-01
2017-12-31-$21.84Mn/a2019-03-14, From 2017-01-01